These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4548357)

  • 1. Transfusion and gel filtration studies in von Willebrand's disease.
    Kernoff PB; Rizza CR; Kaelin AC
    Br J Haematol; 1974 Nov; 28(3):357-70. PubMed ID: 4548357
    [No Abstract]   [Full Text] [Related]  

  • 2. Properties of post-infusion factor VIII in von Willebrand's disease.
    Muntz RH; Ekert H; Helliger H
    Thromb Res; 1974 Aug; 5(2):111-23. PubMed ID: 4547286
    [No Abstract]   [Full Text] [Related]  

  • 3. A 1973 look at hemophilia and von Willebrand's disease.
    Ratnoff OD
    Proc Inst Med Chic; 1973; 29(9):296-304. PubMed ID: 4581203
    [No Abstract]   [Full Text] [Related]  

  • 4. [Factor VIII in hemophilia and von Willebrand's disease].
    Bolland J; Lambotte C
    Rev Med Liege; 1978 Apr; 33(8):284-95. PubMed ID: 349657
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: Transfusion and gel filtration studies in von Willebrand's disease.
    Kernoff PB; Rizza CR; Kaelin AC
    Br J Haematol; 1974 Jun; 27(2):364. PubMed ID: 4546378
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Von Willebrand's disease, hemophilia A, and factor VIII.
    Snyder DS
    Hum Pathol; 1974 May; 5(3):277-89. PubMed ID: 4545385
    [No Abstract]   [Full Text] [Related]  

  • 8. Correction of the platelet abnormality in von Willebrand's disease by cryoprecipitate.
    Weiss HJ; Rogers J
    Am J Med; 1972 Dec; 53(6):734-8. PubMed ID: 4539018
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DDAVP (desmopressin) in the dental management of patients with mild or moderate hemophilia and von Willebrand's disease.
    Vierrou AM; de la Fuente B; Poole AE; Hoyer LW
    Pediatr Dent; 1985 Dec; 7(4):297-301. PubMed ID: 2938080
    [No Abstract]   [Full Text] [Related]  

  • 11. An in vivo study of a new factor VIII high purity preparation.
    Thorell L; Blombäck M; Blombäck B
    Thromb Res; 1983 Jul; 31(2):375-85. PubMed ID: 6415854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress and problems in hemophilia and von Willebrand's disease.
    Abildgaard CF
    Adv Pediatr; 1984; 31():137-77. PubMed ID: 6440429
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies of the human factor VIII/von Willebrand's factor protein I. Comparison of the protein found in normal, von Willebrand's disease and hemophilia A.
    Gralnick HR; Coller BS; Marchesi SL
    Thromb Res; 1975 Feb; 6(2):93-108. PubMed ID: 803726
    [No Abstract]   [Full Text] [Related]  

  • 14. 'Autosomal haemophilia': a variant of von Willebrand's disease.
    Veltkamp JJ; van Tilburg NH
    Br J Haematol; 1974 Jan; 26(1):141-52. PubMed ID: 4546581
    [No Abstract]   [Full Text] [Related]  

  • 15. Survival of iodine-125-labeled factor VIII in patients with von Willebrand's disease.
    Over J; Sixma JJ; Bouma BN; Bolhuis PA; Vlooswijk RA; Beeser-Visser NH
    J Lab Clin Med; 1981 Mar; 97(3):332-44. PubMed ID: 6780640
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence that the platelet retention factor is separate from the factor VIII-related antigen and factor VIII.
    Rubin H; Alter AA; Walker MR; Stefanyshyn M; Scott L; Miotti AB
    J Lab Clin Med; 1976 Jul; 88(1):14-21. PubMed ID: 180215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease.
    Weiss HJ; Sussman II; Hoyer LW
    J Clin Invest; 1977 Aug; 60(2):390-404. PubMed ID: 17621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of plasma fractions in the treatment of hemophilia and von Willebrand's disease.
    Rizza CR; Biggs R
    Prog Hematol; 1969; 6():181-200. PubMed ID: 4889322
    [No Abstract]   [Full Text] [Related]  

  • 19. Factor 8 detection by hemagglutination inhibition: hemophilia A and von Willebrand's disease.
    Stites DP; Hershgold EJ; Perlman JD; Fudenberg HH
    Science; 1971 Jan; 171(3967):196-7. PubMed ID: 5312959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of plasma and/or factor VIII concentrates administration on platelet functions in patients with haemophilia A and von Willebrand's disease (author's transl)].
    Gamba G; Grignani G; Nicolini E; Ascari E
    Haematologica; 1975 Jun; 60(2):168-83. PubMed ID: 808449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.